COMMUNIQUÉS West-GlobeNewswire

Millennium BlockChain Announces $3M Investment in ImpactPPA’s Decentralized Renewable Energy Platform
12/04/2018
Millennium BlockChain partners with ImpactPPA to disrupt renewable energy financing on the blockchain Las Vegas, NV / Manhattan Beach, CA, April 12, 2018 (GLOBE NEWSWIRE) -- Millennium BlockChain , Inc. (the “Company [...]
Novan Advances Organization and Strengthens Leadership Team
12/04/2018
CEO Role No Longer “Interim” Clinical Operations Role Established Finance Team Positioned for the Future MORRISVILLE, N.C., April 12, 2018 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (NASDAQ: NOVN ) today [...]
Active Biotech's partner NeoTX presents new data at AACR demonstrating that ANYARA enhances the efficacy of checkpoint blockade in preclinical models of cancer
12/04/2018
PRESS RELEASE Lund, April 12, 2018 - Active Biotech (NASDAQ STOCKHOLM: ACTI) today announces that its partner NeoTX Therapeutics Ltd. will present new data for ANYARA (Naptumumab Estafenatox) at the Annual Meeting of [...]
Resverlogix Announces TSX Review Update
12/04/2018
CALGARY, Alberta, April 12, 2018 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX: RVX ) announced today it has received a 30-day extension to no later than May 14, 2018 for the TSX’s review [...]
AxoGen, Inc. Announces 2018 Annual Shareholders’ Meeting
12/04/2018
Monday, May 14, 2018 at 4:00 p.m. Eastern Time Hyatt Regency Orlando International Airport ALACHUA, Fla., April 12, 2018 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ: AXGN ), a global leader in developing and marketing [...]
GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences to Present Data on Epidiolex® (cannabidiol oral solution) at the 2018 American Academy of Neurology Annual Meeting
12/04/2018
Long-Term Safety and Efficacy Data in Patients with Lennox-Gastaut Syndrome and Dravet Syndrome to be Presented LONDON, April 12, 2018 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH ) “GW,” “the Company” or “ [...]
Trillium Therapeutics to Report Preclinical Data on TTI-621 and TTI-622 at the AACR Annual Meeting 2018
12/04/2018
TORONTO, April 12, 2018 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (Nasdaq: TRIL ) (TSX: TRIL ) , a clinical-stage immuno-oncology company developing innovative therapies for the treatment of cancer, today announced [...]
Aeglea BioTherapeutics Presents New Phase 1/2 Trial Data Demonstrating Clinically Relevant Treatment Effects in Arginase 1 Deficiency Patients at the 2018 ACMG Annual Clinical Genetics Meeting
12/04/2018
Clinical Outcome Assessment Tools Detected and Quantified Baseline Abnormalities Clinically Relevant Improvement Seen in Multiple Neuromotor Tests Company to Host Clinical Update Conference Call Today at 8:30 a.m. ET [...]
Capricor to Provide Presentation at the Alliance for Regenerative Medicine’s Investor Day
12/04/2018
LOS ANGELES, April 12, 2018 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR ) today announced that it will be among the companies providing presentations at the Alliance for Regenerative Medicine’s (ARM’s) [...]
Tetraphase Pharmaceuticals to Present Data at 28th European Congress of Clinical Microbiology and Infectious Diseases
12/04/2018
– Phase 3 IGNITE4 Results in Complicated Intra-Abdominal Infection Recognized as a ‘Best Rated Abstract’ – – Other Key Eravacycline and TP-6076 Data to Also be Highlighted – WATERTOWN, Mass., April 12, 2018 (GLOBE [...]
Microbot Medical’s Self-Cleaning Shunt Awarded a Grant by the European Commission
12/04/2018
Non-Dilutive Grant Strengthens Balance Sheet for Further Milestone Achievements HINGHAM, Mass., April 12, 2018 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (NASDAQ: MBOT ), a medical device company specializing in the [...]
EyePoint Pharmaceuticals Strengthens Global IP with Notices of Allowance for Two U.S. Patents Related to DEXYCU™
12/04/2018
WATERTOWN, Mass., April 12, 2018 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT ) (ASX:PVA), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic [...]
Akers Biosciences Expands Outsourced US Distribution Capabilities for Heparin PF4 Rapid Test
12/04/2018
THOROFARE, N.J., April 12, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, announces the engagement of [...]
Vascepa® (Icosapent Ethyl) Showed Reductions in Potentially Atherogenic Lipid and Inflammatory Markers in Statin-Treated Patients with Reduced Kidney Function and Persistent High Triglycerides
12/04/2018
BEDMINSTER, N.J. and DUBLIN, Ireland, April 12, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN ), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve [...]
iTeos Therapeutics to Present Preclinical Data from A2A Receptor Antagonist and Anti-TIGIT Antibody Programs at AACR
12/04/2018
iTeos Therapeutics to Present Preclinical Data from A 2A Receptor Antagonist and Anti-TIGIT Antibody Programs at AACR Gosselies, Belgium - April 12, 2018 - iTeos Therapeutics SA, a biotechnology company developing novel [...]
Helsinn Provides Grant for ESMO's Preceptorship Programme for Supportive and Palliative Care
12/04/2018
Helsinn Provides Grant for ESMO's Preceptorship Programme for Supportive and Palliative Care Lugano, Switzerland April 12, 2018 - Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, [...]
Assembly Biosciences Presents Positive Interim Data from Phase 1a and 1b Studies of ABI-H0731 in HBV Patients in a Late-Breaker Session at the EASL Conference
12/04/2018
Robust antiviral activity observed in HBV patients Generally safe and well tolerated Planning underway for Phase 2a studies beginning summer 2018 Company to host conference call on Thursday, April 12 th at 8am ET / 2pm [...]
Medibio finalizes acquisition of Vital Conversations
12/04/2018
SYDNEY, Australia and MINNEAPOLIS, April 12, 2018 (GLOBE NEWSWIRE) -- Medibio Limited ( MEB or the Company ) (ASX:MEB) (OTCQB:MDBIF), a mental health technology company, announces the completion of the acquisition of [...]
Shire plc : Rule 2.9 Announcement
12/04/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 12 April 2018 [...]

Pages